(3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-8-(((2S,3S)-3-hydroxy-2-methylbutanoyl)oxy)-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid; (S)-3’’-Hydroxy Pravastatin Sodium Salt; (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-8-[(2S,3S)-3-hydroxy-2-methyl-1-oxobutoxy]-2-methyl-1-naphthaleneheptanoic Acid Sodium; (3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-8-[[(2S,3S)-3-hydroxy-2-methylbutanoyl]oxy]2-methyl1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic Acid Sodium
Pravastatin Impurity E is a fully characterized chemical compound used as a reference standard of API Pravastatin. The standard offered is compliant with regulatory guidelines. Pravastatin Impurity E is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 722504-45-2
